Clinical Trial

Gut Microbiota, Diet-INDuced Obesity and Type 2 Diabetes in New Caledonia - MIND

Study acronym: MIND
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
In recent years, the global rise in obesity and type 2 diabetes has become a major public health issue. In New Caledonia, 38% of the adult population has a body mass index ≥30. At the same time, the prevalence of type 2 diabetes continues to rise steadily. The burden of these diseases does not affect communities uniformly. While known factors such as diet, physical activity, and socioeconomic conditions play a role, studies have demonstrated the involvement of the gut microbiota in the development of metabolic disorders, particularly obesity and insulin resistance. However, this area remains largely unexplored in New Caledonia and the Pacific.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-09-25.
Trial Details
NCT Number NCT07205913
Lead Sponsor Institut Pasteur
Collaborators: RIKEN Center for Integrative Medical Sciences
Conditions Diabetes Mellitus, Type 2, Obesity
Enrollment 270 participants
Start Date 2026-02-15
Primary Completion 2027-02-15 (estimated)
Study Completion 2027-02-15 (estimated)
Updated on ClinicalTrials.gov 2026-03-09